DK0588177T3 - Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet - Google Patents

Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet

Info

Publication number
DK0588177T3
DK0588177T3 DK93114084T DK93114084T DK0588177T3 DK 0588177 T3 DK0588177 T3 DK 0588177T3 DK 93114084 T DK93114084 T DK 93114084T DK 93114084 T DK93114084 T DK 93114084T DK 0588177 T3 DK0588177 T3 DK 0588177T3
Authority
DK
Denmark
Prior art keywords
protein
interferon
alpha
preparation
beta
Prior art date
Application number
DK93114084T
Other languages
English (en)
Inventor
Daniela Novick
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL103052A external-priority patent/IL103052A/en
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK0588177T3 publication Critical patent/DK0588177T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93114084T 1992-09-03 1993-09-02 Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet DK0588177T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL103052A IL103052A (en) 1992-09-03 1992-09-03 Soluble interferon-alpha receptors,their preparation and pharmaceutical compositions containing them
IL106591A IL106591A (en) 1992-09-03 1993-08-04 Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
DK0588177T3 true DK0588177T3 (da) 2000-05-08

Family

ID=26322502

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93114084T DK0588177T3 (da) 1992-09-03 1993-09-02 Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet

Country Status (11)

Country Link
EP (1) EP0588177B1 (da)
JP (3) JP3662264B2 (da)
AT (1) ATE189262T1 (da)
AU (1) AU674523B2 (da)
CA (1) CA2105449C (da)
DE (1) DE69327693T2 (da)
DK (1) DK0588177T3 (da)
ES (1) ES2142840T3 (da)
GR (1) GR3032891T3 (da)
IL (1) IL106591A (da)
PT (1) PT588177E (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of the interferon-binding protein ALPHA / BETA
US5821078A (en) 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
IL118096A0 (en) * 1996-05-01 1996-09-12 Yeda Res & Dev Antibodies against interferon alpha/beta receptor
EP0859633A2 (en) * 1996-08-16 1998-08-26 Kurt B. Osther Method for treating diabetes
EP1021726B1 (en) * 1996-08-19 2004-12-15 Shaker, Ghassan I. Use of molt4 cd69 expression to determine the presence and activity of interferon inhibitors
PL197568B1 (pl) 1997-12-19 2008-04-30 Applied Research Systems Kompleks zawierający IFN typu I oraz podjednostkę IFNAR, jego zastosowanie, cząsteczka DNA i wektor ją zawierający, komórka gospodarza transformowana wektorem, kompozycja farmaceutyczna, lek, zastosowanie IFNAR, zastosowanie IFN typu I i podjednostki IFNAR, sposób wytwarzania białka fuzyjnego oraz sposób przedłużania okresu trwałości IFN
EP1893646A2 (en) * 2005-06-22 2008-03-05 Genentech, Inc. Methods and compositions for targeting ifnar2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88377A (en) * 1988-11-14 1996-09-12 Yeda Res & Dev Cloning and expression of a protein which modulates cellular response to type I interferon
FR2657881A1 (fr) * 1990-02-05 1991-08-09 Europ Biotechnologie Lab Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides.

Also Published As

Publication number Publication date
JP2004254695A (ja) 2004-09-16
DE69327693T2 (de) 2000-09-07
CA2105449A1 (en) 1994-03-04
ES2142840T3 (es) 2000-05-01
AU674523B2 (en) 1997-01-02
AU4609693A (en) 1994-03-10
CA2105449C (en) 2010-07-20
GR3032891T3 (en) 2000-07-31
IL106591A0 (en) 1993-12-08
EP0588177B1 (en) 2000-01-26
JP3662264B2 (ja) 2005-06-22
ATE189262T1 (de) 2000-02-15
JP2005162762A (ja) 2005-06-23
DE69327693D1 (de) 2000-03-02
EP0588177A3 (en) 1994-08-17
IL106591A (en) 2008-03-20
JP3907661B2 (ja) 2007-04-18
PT588177E (pt) 2000-05-31
EP0588177A2 (en) 1994-03-23
JPH06220100A (ja) 1994-08-09

Similar Documents

Publication Publication Date Title
DE68904300D1 (de) Medizinische aerosolformulierungen.
DE68905387D1 (de) Aminosaeure-nahrungsmittelzusammensetzungen.
IL85609A0 (en) Phenyl carbamate,its preparation and pharmaceutical compositions containing it
EP0302900A4 (en) MEDICINAL PRODUCTS WITH REPRESENTED TASTE.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
FI921036A0 (fi) Tgf-b-proteinkompositioner foer inhibering av cellproliferation.
FI864559A (fi) Nya insulinderivat och farmaceutiska preparat innehaollande dessa derivat.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
MX9204240A (es) Montaje distribuidor y de mezclado de dos etapas para preparaciones tal como cementos dentales.
FI883673A (fi) Farmaceutiska kompositioner.
NO862439D0 (no) Farmasoeytiske preparater.
DK0588177T3 (da) Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet
DE69009795D1 (de) Muramylpeptid-Derivate und diese enthaltende immunregulierende Zusammensetzungen.
DK439589D0 (da) Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme
NO874193D0 (no) Farmasoeytiske preparater.
DE3689767D1 (de) Immunverstärker und verwandte Zusammensetzungen.
FI923751A (fi) Hexahydrobenso/f/kinolinoner
FR2652742B1 (fr) Compositions anallergiques cosmetiques et dermo-pharmaceutiques.
AU2557288A (en) Synergistic antifungal protein and compositions containing same
MA21232A1 (fr) Compositions de shampooings.
ITMI932544A0 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro bovino.
IT1214187B (it) Composizioni farmaceutiche antimicotiche.
ITMI931417A0 (it) Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro equino